These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 27786042)

  • 1. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
    Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
    J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.
    Luongo C; De Stefano MA; Ambrosio R; Volpe F; Porcelli T; Golia V; Bellevicine C; Troncone G; Masone S; Damiano V; Matano E; Klain M; Schlumberger M; Salvatore D
    Thyroid; 2023 Mar; 33(3):294-300. PubMed ID: 36680751
    [No Abstract]   [Full Text] [Related]  

  • 4. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil.
    Penna GC; Bensenor IM; Bianco AC; Ettleson MD
    J Clin Endocrinol Metab; 2024 Sep; 109(10):2504-2512. PubMed ID: 38506164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
    Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study.
    Butler PW; Smith SM; Linderman JD; Brychta RJ; Alberobello AT; Dubaz OM; Luzon JA; Skarulis MC; Cochran CS; Wesley RA; Pucino F; Celi FS
    Thyroid; 2010 Dec; 20(12):1407-12. PubMed ID: 21054208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Resistance to Exogenous Thyroxine in Humans.
    Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
    Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
    Tariq A; Wert Y; Cheriyath P; Joshi R
    South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.
    Panicker V; Saravanan P; Vaidya B; Evans J; Hattersley AT; Frayling TM; Dayan CM
    J Clin Endocrinol Metab; 2009 May; 94(5):1623-9. PubMed ID: 19190113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
    Takahashi S; Ito M; Masaki Y; Hada M; Minakata M; Kohsaka K; Nakamura T; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
    Endocr J; 2021 Mar; 68(3):353-360. PubMed ID: 33239477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid function from birth to adolescence in Prader-Willi syndrome.
    Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
    J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levothyroxine Therapy Achieves Physiological FT3/FT4 Ratios at Higher than Normal TSH Levels: A Novel Justification for T3 Supplementation?
    Strich D; Chay C; Karavani G; Edri S; Gillis D
    Horm Metab Res; 2018 Nov; 50(11):827-831. PubMed ID: 30396211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
    Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free triiodothyronine/free thyroxine ratio rather than thyrotropin is more associated with metabolic parameters in healthy euthyroid adult subjects.
    Park SY; Park SE; Jung SW; Jin HS; Park IB; Ahn SV; Lee S
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):87-96. PubMed ID: 28374508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
    Wiersinga WM
    Eur J Endocrinol; 2017 Dec; 177(6):R287-R296. PubMed ID: 28855267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
    van den Berg EH; van Tienhoven-Wind LJ; Amini M; Schreuder TC; Faber KN; Blokzijl H; Dullaart RP
    Metabolism; 2017 Feb; 67():62-71. PubMed ID: 28081779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?
    Peterson SJ; McAninch EA; Bianco AC
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4964-4973. PubMed ID: 27700539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.